Ambrx
Ambrx is a California-based biopharmaceutical company that researches and develops antibody-drug and immuno-oncology conjugates for the treatment of cancer.
Business Model:
Revenue: $7.5M
Employees: 51-200
Industries / Tags:
Detailed Ambrx Information
Geographic Data
Address: 10975 N Torrey Pines Rd.
City: San Diego
State: CA
Zip: 92037
Country: US
Financial Info
Stage:
private equity
Raised Last:
$200M
Raised Total:$348M
Social
Metrics
3,250,846Website Global Rank
3,867Website Monthly Traffic
Twitter Followers
Description
Ambrx is a California-based biopharmaceutical company that researches and develops antibody-drug and immuno-oncology conjugates for the treatment of cancer.
Contact Phone:
+18587293339
Contact Email:
Ambrx went public on 6/18/2021 on the NYSE
Listed Exchange:
NYSE
IPO Date:
6/18/2021
IPO Valuation:
$5B
Ticker Symbol:
AMAM
IPO Price:
$18/share
Amount Raised:
$126M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
